We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Why I’d still shun Carillion plc shares at less than 20p

G A Chester discusses why he’d sell Carillion plc (LON:CLLN) but buy another turnaround stock.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Embattled construction services group Carillion (LSE: CLLN) has been sliding ever deeper into financial trouble. And a story from Sky News at the weekend claimed it’s now “racing to secure new funding within weeks to avoid collapse.”

A spokesman said it’s finalising a business plan to present to its syndicate of lenders on Wednesday. The company made no official statement to the stock market this morning but its shares are up 17% to 22p, as I’m writing. This values it at £95m, but the trouble is, total debt is £1.5bn.

Should you buy Capita Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

1p a share target

Sky reported that Carillion has come up with a rescue plan, which “would involve handing back some lossmaking contracts, revising the terms of others and potentially accepting financial support from the Government if it cannot secure it from private sector sources.”

This may account for the rise in the share price today. However, institutional shareholders have deserted the company in droves and I believe the price is now being driven by short-term traders and naive retail investors. They could think they see a wide margin of safety in the company’s P/E of one, but fail to appreciate the gravity and implications of its financial position.

Back in October, when the shares were trading at 47p, I drew readers’ attention to a note from analysts at UBS, who saw “no material equity value left for current shareholders” and put a 1p target on the shares. At that time, I thought this was an extreme, but far from negligible, outcome and rated the stock a ‘sell’. Subsequent events (including news of an FCA investigation into announcements made by the company last year) have persuaded me it’s a probable outcome.

In the kind of situation of extreme distress in which Carillion finds itself, a financial restructuring almost invariably involves a hugely dilutive debt-for-equity swap and fundraising and leaves existing shareholders with a token few million of equity. In Carillion’s case, this would equate to around the 1p a share of UBS’s target. As such, I rate the stock a ‘sell’ at the current price — indeed, at almost any price.

A credible turnaround stock?

Short-sellers, who went through Carillion’s accounts with a fine toothcomb a few years ago, concluded that the company’s accounting was aggressive and that its many acquisitions obscured a multitude of sins. They reckoned these issues also tainted other companies in the sector, including Capita (LSE: CPI).

Like Carillion, Capita has had to book multi-million pound impairments. However, Capita’s haven’t been as extreme and, unlike its troubled peer, it’s been able to bolster its balance sheet with an £888m sale of one of its businesses. While the company has said it expects to record further impairments in its results for the year ended 31 December, it has also said it expects year-end net debt/EBITDA to be around 2.25. This is a reasonable level and down from 2.9 at 30 June.

At a current share price of 410p, Capita trades on a P/E of 8.5. I see risk here as still elevated but infinitely lower than at Carillion. On the basis of debt being under control, the low earnings multiple and credible turnaround prospects, I rate Capita a ‘buy’.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A row of satellite radars at night
Investing Articles

This ex-penny stock has crushed Rolls-Royce shares over 5 years! Is there more to come?

With all eyes on Rolls-Royce shares, this growth share with a connection to SpaceX might have gone unnoticed by a…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

With a 6.4% yield and P/E of 10 is this FTSE dividend stock a hidden passive income gem?

Building a portfolio of solid UK dividend stocks isn't hard. Paul Summers takes a closer look at one high-yielding candidate…

Read more »

Black woman using smartphone at home, watching stock charts.
Growth Shares

At 112p, where next for the Lloyds share price? 168p or 56p?

Jon Smith mulls over the direction going forward for the Lloyds share price, and explains why two very different scenarios…

Read more »

Investing Articles

This dividend stock has a 7.3% yield, and Stocks and Shares ISA investors are buying!

Looking to move from a Cash ISA to a Stocks and Shares ISA to target passive income? Alan Oscroft has…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

Could Rolls-Royce shares lock in another 34% gain before Christmas?

Mark Hartley takes a look at some of the more optimistic price targets for Rolls-Royce, and considers a best-case scenario.…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »